For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

IC44 - Anti-VEGF Failure: Stop, Switch or Rethink?

27/11/2026
Golden Sand
12:00
12:55

KSOSID1113

Dr.Jyoti Prakash Vyas
Anti-VEGF Failure: Stop, Switch or Rethink?
Despite the status of anti-VEGF therapy as the standard of care in medical retina, a significant subset of patients fail to achieve the visual and anatomical outcomes observed in pivotal clinical trials. This instruction course provides a structured, evidence-based approach to managing suboptimal treatment responses within resource-variable settings. We intend to define the spectrum of anti-VEGF failure—distinguishing between primary non-responders, tachyphylaxis, and persistent exudation—while identifying key clinical and multimodal imaging biomarkers that predict poor prognosis. By moving beyond a "one-size-fits-all" injection strategy, this course equips clinicians with actionable diagnostic and therapeutic algorithms to optimize patient outcomes in daily practice.
Vitreoretinal surgeon, in clinical practice for over a 16 years,at a tertiary referral eye hospital in Kerala, with an academic focus on medical and surgical retina, anti-VEGF pharmacotherapy, and the multimodal imaging of macular and choroidal disease. Runs regular journal clubs and case-based teaching sessions for retina fellows, postgraduates and comprehensive ophthalmologists. Sustained interest in the gap between what randomised trials report and what actually happens in our clinics, and in building working protocols that survive contact with real patients. 
Membership No Name Topic ORDER NO Duration
KSOSID1113 Dr.Jyoti Prakash Vyas Defining the problem statement - non responders, tachyphylaxis 1 8
KSOSID1496 Dr.Anubhav Goyal DME that will not settle — what the registries tell us and the trials did not 2 8
KSOSID1468 Dr.Shishir Verghese MNV and the suboptimal response : Switching & Rescue Strategies 3 8
KSOSID1810 Dr.Prithvi Chandrakanth PCV Unmasked: When Anti-VEGF Fails and the Diagnosis Reveals Itself 4 8
KSOSID1113 Dr.Jyoti Prakash Vyas Real world case based discussion across all etiologies 5 8
KSOSID0727 Dr.Gopal S Pillai Specific role of Brolucizumab in AMD 6 8